Aquestive Therapeutics Inc (NAS:AQST)
$ 5.09 -0.11 (-2.12%) Market Cap: 463.49 Mil Enterprise Value: 409.35 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Q3 2020 Aquestive Therapeutics Inc Earnings Call Transcript

Nov 05, 2020 / 01:00PM GMT
Release Date Price: $5.49 (+3.98%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Q3 2020 Aquestive Therapeutics Inc. Earnings Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Stephanie Carrington, Westwicke Investor Relations. Thank you. Please go ahead, ma'am.

Stephanie Carrington
ICR, LLC - SVP

Thank you, operator. Good morning and welcome to today's call. I'm joined by Keith Kendall, President and Chief Executive Officer; and John Maxwell, Chief Financial Officer, who will be providing an overview of recent business developments and performance of the company in the 3rd quarter. We expect today's call to last approximately 60 minutes. The company's remarks today correspond with the earnings release that was issued after market closed yesterday. In addition, a recording of today's call will be made available on Aquestive's website within the Investors section shortly following the conclusion of this call. This call will also include a discussion of certain non-GAAP financial measures. A reconciliation to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot